Endpoints News 2025-12-16 J&J backs financing round for Stanford CAR-T cell therapy spinout Link Cell
Endpoints News 2025-12-16 OrsoBio obesity data; Monte Rosa's prostate cancer pill; Development pacts for Adaptive and SandboxAQ
Endpoints News 2025-12-16 Chronic pain biotech Ambros Therapeutics emerges with $125M and Vivek Ramaswamy on board
Endpoints News 2025-12-16 Aeovian gets $55M for tuberous sclerosis complex, to explore prospects in obesity
Endpoints News 2025-12-15 FDA wants to use more real-world data and calls again for early-phase trials reform
Endpoints News 2025-12-15 Enhertu combo wins FDA approval for first-line use in metastatic breast cancer
Endpoints News 2025-12-15 FDA speeds up review of J&J's multiple myeloma combo treatment following positive data
Endpoints News 2025-12-15 With GLP-1 microdoses, Noom targets lower-BMI group outside FDA obesity drug labels
Endpoints News 2025-12-15 Aviceda's geographic atrophy drug fails mid-stage study. Can it do better in Phase 3?
Endpoints News 2025-12-15 Sanofi returns to Dren Bio for another B cell depletion therapy at $100M upfront
Endpoints News 2025-12-15 Western genetic medicine makers turn to Chinese investigator-initiated trials